Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Secondary Prevention"" wg kryterium: Temat


Tytuł:
Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study.
Autorzy:
Wang X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Li T; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Li Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Wang Q; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Cai Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Wang Z; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Shi Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China.
Yang T; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China. .
Zheng X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, No.300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 29; Vol. 22 (1), pp. 318. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperthyroidism*/diagnosis
Hyperthyroidism*/drug therapy
Graves Disease*/drug therapy
Adult ; Humans ; Secondary Prevention ; Prospective Studies ; Reproducibility of Results ; Antithyroid Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.
Autorzy:
Akl E; McGill University, Montreal, Canada.
Sahami N; McMaster University, Hamilton, Canada.
Labos C; McGill University, Montreal, Canada.
Genest J; McGill University, Montreal, Canada.
Zgheib A; McGill University, Montreal, Canada.
Piazza N; McGill University, Montreal, Canada.
Jolly S; McMaster University, Hamilton, Canada.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2024 Mar 12; Vol. 2024, pp. 8646351. Date of Electronic Publication: 2024 Mar 12 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Cardiovascular Diseases*/prevention & control
Myocardial Infarction*/epidemiology
Stroke*/prevention & control
Stroke*/epidemiology
Coronary Artery Disease*/drug therapy
Humans ; Colchicine/adverse effects ; Secondary Prevention ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis.
Autorzy:
Fang G; Department of Infectious Diseases, The Affiliated Hospital of Guangdong Medical University, No.57 Renmin Avenue South, 524000, Xiashan, Zhanjiang, Guangdong, China.
Liu S; Department of Infectious Diseases, The Affiliated Hospital of Guangdong Medical University, No.57 Renmin Avenue South, 524000, Xiashan, Zhanjiang, Guangdong, China.
Liu B; Laboratory of Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, 524000, Zhanjiang, Guangdong, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Mar 04; Vol. 24 (1), pp. 94. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Hepatic Encephalopathy*/drug therapy
Hepatic Encephalopathy*/prevention & control
Humans ; Network Meta-Analysis ; Rifaximin/therapeutic use ; Risk Factors ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Diet in secondary prevention: the effect of dietary patterns on cardiovascular risk factors in patients with cardiovascular disease: a systematic review and network meta-analysis.
Autorzy:
Bonekamp NE; Department of Vascular Medicine, University Medical Center Utrecht, PO Box 85500, Utrecht, 3508 GA, the Netherlands.
Cruijsen E; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands.
Geleijnse JM; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands.
Winkels RM; Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands.
Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, PO Box 85500, Utrecht, 3508 GA, the Netherlands. .
Morris PB; Department of Cardiology, Medical University of South Carolina, Charleston, SC, USA.
Koopal C; Department of Vascular Medicine, University Medical Center Utrecht, PO Box 85500, Utrecht, 3508 GA, the Netherlands.
Pokaż więcej
Źródło:
Nutrition journal [Nutr J] 2024 Feb 08; Vol. 23 (1), pp. 18. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Cardiovascular Diseases*/prevention & control
Humans ; Dietary Patterns ; Network Meta-Analysis ; Body Weight ; Diet, Fat-Restricted ; Heart Disease Risk Factors ; Carbohydrates ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Optimising the implementation of digital-supported interventions for the secondary prevention of heart disease: a systematic review using the RE-AIM planning and evaluation framework.
Autorzy:
de Moel-Mandel C; School of Psychology & Public Health, La Trobe University, Melbourne, VIC, Australia.
Lynch C; School of Psychology & Public Health, La Trobe University, Melbourne, VIC, Australia. .; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. .; NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, Melbourne, VIC, Australia. .; Northern Health, Melbourne, VIC, Australia. .
Issaka A; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, Melbourne, VIC, Australia.
Braver J; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, Melbourne, VIC, Australia.; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Zisis G; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, Melbourne, VIC, Australia.; Northern Health, Melbourne, VIC, Australia.; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Carrington MJ; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.; Western Health, Melbourne, VIC, Australia.
Oldenburg B; School of Psychology & Public Health, La Trobe University, Melbourne, VIC, Australia.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, Melbourne, VIC, Australia.; Northern Health, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Dec 04; Vol. 23 (1), pp. 1347. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Heart Diseases*
Humans ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).
Autorzy:
Vafaei S; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Ciebiera M; Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 00-189 Warsaw, Poland.; Warsaw Institute of Women's Health, 00-189 Warsaw, Poland.; Development and Research Center of Non-Invasive Therapies, Pro-Familia Hospital, 35-302 Rzeszow, Poland.
Omran MM; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Ghasroldasht MM; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Yang Q; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Leake T; The White Dress Project, Atlanta, GA 30309, USA.
Wolfe R; The White Dress Project, Atlanta, GA 30309, USA.
Ali M; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Al-Hendy A; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 04; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Uterine Neoplasms*/prevention & control
Uterine Neoplasms*/pathology
Leiomyoma*/prevention & control
Leiomyoma*/diagnosis
Uterine Myomectomy*/adverse effects
Humans ; Female ; Quality of Life ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Use of co-design methodology in the development of cardiovascular disease secondary prevention interventions: A scoping review.
Autorzy:
Talevski J; Institute for Physical Activity and Nutrition Research (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.; School of Rural Health, Monash University, Warragul, Victoria, Australia.; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, Victoria, Australia.
Kulnik ST; Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.; Faculty of Health, Social Care and Education, Kingston University and St George's University of London, London, UK.
Jessup RL; School of Rural Health, Monash University, Warragul, Victoria, Australia.; Academic and Research Collaborative in Health, La Trobe University, Bundoora, Victoria, Australia.; Allied Health Research, Northern Health, Epping, Victoria, Australia.
Falls R; Western Centre for Health Research and Education, Sunshine Hospital, St Albans, Victoria, Australia.
Cvetanovska N; School of Rural Health, Monash University, Warragul, Victoria, Australia.; Office of Research, Northern Health, Epping, Victoria, Australia.
Beauchamp A; School of Rural Health, Monash University, Warragul, Victoria, Australia.; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, Victoria, Australia.; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia.
Pokaż więcej
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2023 Feb; Vol. 26 (1), pp. 16-29. Date of Electronic Publication: 2022 Nov 10.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*/prevention & control
Secondary Prevention*/methods
Adult ; Humans
Czasopismo naukowe
Tytuł:
The role of community pharmacists in primary and secondary prevention of skin cancer: an evaluation of a Flemish skin cancer prevention campaign.
Autorzy:
Proesmans K; Faculty of Pharmaceutical Sciences, Department of Bio-analysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.
Van Vaerenbergh F; Faculty of Pharmaceutical Sciences, Department of Bio-analysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.
Lahousse L; Faculty of Pharmaceutical Sciences, Department of Bio-analysis, Pharmaceutical Care Unit, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2023 Dec 12; Vol. 23 (1), pp. 2490. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Skin Neoplasms*/prevention & control
Melanoma*
Female ; Humans ; Adolescent ; Middle Aged ; Male ; Sunscreening Agents/therapeutic use ; Pharmacists ; Secondary Prevention ; Counseling
Czasopismo naukowe
Tytuł:
The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial.
Autorzy:
Donate APG; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
de Macedo EC; Laboratório de Neurociência Cognitiva e Social, Centro de Ciências Biológicas e da Saúde, Universidade Presbiteriana Mackenzie, SP, São Paulo, Brazil.
Bedendo A; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
Félix Júnior I; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
Gallo GG; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
Opaleye ES; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
Noto AR; Department of Psychobiology, Núcleo de Pesquisa em Saúde e Uso de Substância, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 07; Vol. 18 (11), pp. e0293502. Date of Electronic Publication: 2023 Nov 07 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mindfulness*/methods
Substance-Related Disorders*/therapy
Gambling*
Middle Aged ; Humans ; Impulsive Behavior ; Secondary Prevention/methods
Czasopismo naukowe
Tytuł:
Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort study.
Autorzy:
Chan CC; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Tung YC; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Lee KT; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Chan YH; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Chu PH; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Sep; Vol. 16 (9), pp. 1594-1605. Date of Electronic Publication: 2023 Jul 23.
Typ publikacji:
Journal Article
MeSH Terms:
Myocardial Infarction*/prevention & control
Humans ; Clopidogrel/adverse effects ; Cohort Studies ; Retrospective Studies ; Secondary Prevention ; Hemorrhage/chemically induced ; Hemorrhage/prevention & control ; Treatment Outcome ; Platelet Aggregation Inhibitors/adverse effects
Czasopismo naukowe
Tytuł:
Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
Autorzy:
Lv J; Xijing Hospital, Fourth Military Medical University, No. 127 Changle west road, Xincheng district, Shaanxi Province, 710000, Xi'an, China.
Zhao D; Xijing Hospital, Fourth Military Medical University, No. 127 Changle west road, Xincheng district, Shaanxi Province, 710000, Xi'an, China.
Zhao G; Xijing Hospital, Fourth Military Medical University, No. 127 Changle west road, Xincheng district, Shaanxi Province, 710000, Xi'an, China. .; School of Medicine, Northwestern University of China, No. 229, Taibai North Road, Beilin District, Shaanxi Province, 710000, Xi'an, China. .
Xie Z; School of Medicine, Northwestern University of China, No. 229, Taibai North Road, Beilin District, Shaanxi Province, 710000, Xi'an, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Aug 19; Vol. 22 (1), pp. 305. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Benzofurans*/adverse effects
Ischemic Stroke*/prevention & control
Secondary Prevention*
Aspirin/therapeutic use ; Clopidogrel/therapeutic use ; Double-Blind Method ; Humans ; Internet ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Evaluation of the secondary and tertiary prevention strategies against occupational contact dermatitis in Germany: A systematic review.
Autorzy:
Ahlström MG; National Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Dietz JB; National Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Wilke A; Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.; Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany.
Johansen JD; National Allergy Research Centre, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
John SM; Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.; Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany.
Brans R; Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.; Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany.
Pokaż więcej
Źródło:
Contact dermatitis [Contact Dermatitis] 2022 Aug; Vol. 87 (2), pp. 142-153. Date of Electronic Publication: 2022 Apr 03.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Dermatitis, Occupational*/prevention & control
Secondary Prevention*/methods
Tertiary Prevention*/methods
Employment/statistics & numerical data ; Germany ; Humans ; Program Evaluation ; Quality of Life ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Designing a Multilevel Strategy to Enhance Secondary Prevention of Heart Disease.
Autorzy:
Tenner K; Department of Family Medicine, Atrius Health, Newton, MA, USA.
Rao A; Department of Internal Medicine, Atrius Health, Newton, MA, USA.
Dvorkis Y; Atrius Health, Newton, MA, USA.
Cortell ED; Department of Radiology, Atrius Health, Newton, MA, USA.
Dejam A; Department of Cardiology, Atrius Health, Newton, MA, USA.
Zambrano J; Department of Internal Medicine, Atrius Health, Newton, MA, USA.
Isaac T; Atrius Health and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
The Permanente journal [Perm J] 2023 Jun 15; Vol. 27 (2), pp. 13-17. Date of Electronic Publication: 2023 Apr 18.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Coronary Artery Disease*/prevention & control
Cardiovascular Diseases*/prevention & control
Humans ; Retrospective Studies ; Secondary Prevention ; Risk Factors
Czasopismo naukowe
Tytuł:
Is there benefit to adding ezetimibe to a statin for the secondary prevention of CVD?
Autorzy:
Reddy V; Department of Family Medicine, University of North Carolina, Chapel Hill.
Allison J; Department of Family Medicine, University of North Carolina, Chapel Hill.
Mounsey A; Department of Family Medicine, University of North Carolina, Chapel Hill.
Pokaż więcej
Źródło:
The Journal of family practice [J Fam Pract] 2023 Jun; Vol. 72 (5), pp. 227-229.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Cardiovascular Diseases*/prevention & control
Anticholesteremic Agents*/therapeutic use
Adult ; Humans ; Ezetimibe/therapeutic use ; Rosuvastatin Calcium ; Secondary Prevention
Czasopismo naukowe
Tytuł:
Medication self-management interventions for persons with stroke: A scoping review.
Autorzy:
Cadel L; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.
Cimino SR; Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Bradley-Ridout G; Gerstein Science Information Centre, University of Toronto, Toronto, ON, Canada.
Hitzig SL; Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Occupational Science and Occupational Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Patel T; University of Waterloo School of Pharmacy, Kitchener, ON, Canada.; Schlegel-University of Waterloo Research Institute of Aging, Waterloo, ON, Canada.
Ho CH; Division of Physical Medicine & Rehabilitation, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Packer TL; Schools of Occupational Therapy and Health Administration, Dalhousie University, Halifax, NS, Canada.; Department of Rehabilitation, Radboud University Medical Centre, Nijmegen, The Netherlands.
Lofters AK; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.; Women's College Research Institute, Toronto, ON, Canada.
Hahn-Goldberg S; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; OpenLab, University Health Network, Toronto, ON, Canada.
McCarthy LM; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.
Guilcher SJT; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.; Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; St. John's Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 May 18; Vol. 18 (5), pp. e0285483. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Self-Management*
Stroke*/drug therapy
Stroke*/prevention & control
Adult ; Humans ; Chronic Disease ; Pharmaceutical Preparations ; Secondary Prevention ; Medication Adherence
Czasopismo naukowe
Tytuł:
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study.
Autorzy:
Yoo J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Republic of Korea.
Jeon J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Republic of Korea.
Baik M; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Republic of Korea.
Kim J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Republic of Korea. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2023 May 05; Vol. 22 (1), pp. 106. Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Ischemic Stroke*
Insulin Resistance*
Stroke*/diagnosis
Stroke*/epidemiology
Stroke*/prevention & control
Thiazolidinediones*/adverse effects
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Humans ; Pioglitazone/adverse effects ; Hypoglycemic Agents/adverse effects ; Case-Control Studies ; Secondary Prevention ; Logistic Models
Czasopismo naukowe
Tytuł:
Clinical Characteristics, Achievement of Secondary Prevention Goals, and Outcomes of Patients with Recurrent Acute Coronary Syndrome.
Autorzy:
Tara S; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Yamamoto T; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Sakai S; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Kimura T; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Asano K; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Fujimoto Y; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Shiomura R; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Matsuda J; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Kadooka K; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Takahashi K; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Ko T; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Sangen H; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Saiki Y; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Nakata J; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Hosokawa Y; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
Takano H; Department of Cardiovascular Medicine, Nippon Medical School.
Shimizu W; Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.; Department of Cardiovascular Medicine, Nippon Medical School.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2021 Nov 17; Vol. 88 (5), pp. 432-440. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Secondary Prevention*
Acute Coronary Syndrome/*prevention & control
Cholesterol, LDL/*blood
Adult ; Aged ; Aged, 80 and over ; Diabetes Mellitus ; Goals ; Humans ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma.
Autorzy:
Alqahtani SA; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD 21287, USA.; Liver Transplant Center, and Biostatistics, Epidemiology, and Scientific Computing Department, King Faisal Specialist Hospital & Research Center, Riyadh 11564, Saudi Arabia.
Colombo M; Liver Center, IRCCS San Raffaele Hospital, 20132 Milan, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Nov 09; Vol. 10 (11). Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Secondary Prevention*
Carcinoma, Hepatocellular/*prevention & control
Hepatitis, Viral, Human/*drug therapy
Liver Neoplasms/*prevention & control
Animals ; Carcinoma, Hepatocellular/virology ; Hepatitis, Viral, Human/virology ; Humans ; Liver Neoplasms/virology ; Models, Biological ; Oxidative Stress
Czasopismo naukowe
Tytuł:
A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.
Autorzy:
Sadaf H; Punjab Medical College, University of Health Science, Faisalabad, Pakistan.
Desai VR; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.
Misra V; Department of Neurology, Houston Methodist Neurological Institute, Houston, Texas, USA.
Golanov E; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.
Hegde ML; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Villapol S; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Karmonik C; Translational Imaging Center, Houston Methodist Research Institute, Houston, Texas, USA.
Regnier-Golanov A; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.
Sayenko D; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Horner PJ; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Krencik R; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Weng YL; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Vahidy FS; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Outcomes Research, Houston Methodist Research Institute, Houston, Texas, USA.
Britz GW; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.; Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Nov; Vol. 8 (11), pp. 2211-2221. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematologic Agents*
Neurological Rehabilitation*
Neurosurgical Procedures*
Secondary Prevention*
Stem Cell Transplantation*
Cerebral Hemorrhage/*therapy
Cerebral Hemorrhage/drug therapy ; Cerebral Hemorrhage/surgery ; Humans
Czasopismo naukowe
Tytuł:
The correlates and extent of prescribing of medications for alcohol relapse prevention in England.
Autorzy:
Donoghue K; Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.; Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Pokaż więcej
Źródło:
Addiction (Abingdon, England) [Addiction] 2021 Nov; Vol. 116 (11), pp. 3019-3026. Date of Electronic Publication: 2021 May 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Secondary Prevention*
Cross-Sectional Studies ; England/epidemiology ; Female ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies